ScholarIQanswers from OpenAlex & ORCID
Wenliang Tan
ResearcherPublications, citations & collaboration network
Wenliang Tan is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Wenliang Tan have?
ScholarIQindexed works
Wenliang Tan has 66 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Wenliang Tan have?
ScholarIQcitation count
Wenliang Tan has 911 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Wenliang Tan?
ScholarIQh-index
Wenliang Tan has an h-index of 18 in OpenAlex.
What is the i10-index of Wenliang Tan?
ScholarIQi10-index
Wenliang Tan has an i10-index of 25 in OpenAlex.
What is the ORCID of Wenliang Tan?
ScholarIQorcid
The ORCID for Wenliang Tan is on the source record.
What is the OpenAlex record for Wenliang Tan?
ScholarIQopenalex
The OpenAlex for Wenliang Tan is on the source record.
What are the most-cited papers on Wenliang Tan?
ScholarIQmost cited works
TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma
Wenliang Tan, Xuan Luo, Wenda Li, Jinyi Zhong, Jun Cao, Sicong Zhu, Xianqing Chen, Rui Zhou, Changzhen Shang, Yajin Chen
Is lymph node dissection necessary for resectable intrahepatic cholangiocarcinoma? A systematic review and meta-analysis
Rui Zhou, Dihan Lu, Wenda Li, Wenliang Tan, Sicong Zhu, Xianqing Chen, Jun Min, Changzhen Shang, Yajin Chen
SOX2 regulates radioresistance in cervical cancer via the hedgehog signaling pathway
Chunxian Huang, Huaiwu Lu, Jing Li, Xiaofei Xie, Fan Li, Dongyan Wang, Wenliang Tan, Yaxian Wang, Zhongqiu Lin, Tingting Yao
GPX2 is a potential therapeutic target to induce cell apoptosis in lenvatinib against hepatocellular carcinoma
Wenliang Tan, Kelin Zhang, Xinming Chen, Lei Yang, Sicong Zhu, Yingcheng Wei, Zhiqin Xie, Yajin Chen, Changzhen Shang
Pretreatment CT-based machine learning radiomics model predicts response in unresectable hepatocellular carcinoma treated with lenvatinib plus PD-1 inhibitors and interventional therapy
Yonglin Hua, Zhixian Sun, Yuxin Xiao, Huilong Li, Xiaowu Ma, Xuan Luo, Wenliang Tan, Zhiqin Xie, Ziyu Zhang, Chenwei Tang, Hongkai Zhuang, Weikai Xu, Haihong Zhu, Yajin Chen, Changzhen Shang